Answering Critics of The Bredesen Protocol
Apollo Health is dedicated to delivering the Bredesen Protocol®. As healthcare disruptors, we believe everyone deserves access to Dr. Dale Bredesen’s groundbreaking approach that has the potential to reduce the global burden of dementia.
The Bredesen Protocol has the world’s only clinical success in treating Alzheimer’s and shows that Alzheimer’s can be prevented and even reversed in the early stages. However, the gap between proof and adoption in medical care remains large. Millions of people are suffering now and millions more already have the pathophysiology that leads to Alzheimer’s disease without being aware.
We cannot remain silent and let the naysayers disregard this lifesaving approach; too many lives are at stake.
Science-Backed Success Treating Cognitive Decline
Dr. Bredesen’s clinical trial, published in the Journal of Alzheimer’s Disease, revolutionized how Alzheimer’s should be treated.
By addressing a multifactorial disease with a precision-medicine approach that specifically identifies and addresses what each patient requires instead of blindly treating with a single drug, he has finally accomplished what no one else has been able to achieve — the reversal of early-stage Alzheimer’s disease.
This unprecedented success came after spending more than three decades in the laboratory, publishing over 200 peer-reviewed papers that meticulously provide the underpinnings for his Alzheimer’s hypothesis.
Dr. Bredesen suggests that Alzheimer’s results from an imbalance in the brain’s neuroplasticity signaling. As we age and are exposed to brain insults, the damage begins to exceed our capacity to repair, resulting in a downsizing of the brain’s ability and subsequent cognitive decline.
He hypothesized that by identifying and addressing the contributors to each patient’s cognitive decline, he could change their biochemistry and provide optimal conditions for their brains to thrive. That theory was put to the test with a series of successful case studies, a clinical trial in 2022, and now a larger, randomized clinical trial. Subsequently, others using this approach, have also published peer-reviewed papers showing cognitive benefits far beyond that of any pharmaceutical to date.
Criticism of the Bredesen Protocol from the Scientific Community
While the Amyloid Hypothesis has failed to lead to any clinical improvement after decades of trials, amyloid still remains the leading subject of research for a cure to Alzheimer’s and many in the research community would like us to wait for when the breakthrough will finally happen. Don’t worry that much of the seminal work was recently revealed to be fraudulent. Pay no attention to the studies outlining dementia’s links to viruses, insulin, or cardiovascular health, which are all addressed by the Bredesen Protocol.
The very people who’ve failed to demonstrate improvement in a study of any size say our studies are “too small.” We’re just “too expensive,” they shout, even though the Bredesen Protocol is offered at a fraction of the cost of standard of care with no side effects other than improved health.
No surprise, those who failed to understand that Alzheimer’s is not a single disease, but rather a complex syndrome that needs a multifactorial approach have cried foul, claiming that Dr. Bredesen hasn’t followed the scientific method. His critics claim that he changed too many variables at once. Even worse, he dared to look beyond pharmaceuticals to diet and lifestyle to address the chronic diseases that lead to Alzheimer’s disease.
Sadly, even as more evidence accumulates for the Bredesen Protocol, “evidence-based medicine” continues to disregard alternative theories (even when they’re successful!) in lieu of pharmaceutical solutions as detailed in The Corruption of Evidence-Based Medicine: Killing for Profit.
Is It Too Soon To Offer The Bredesen Protocol?
The main criticism against Apollo Health and Dr. Dale Bredesen is that we have given patients access to our treatment protocol too early.
It’s important to remember that mainstream medicine offers no effective, sustainable treatment for Alzheimer’s. So, the question becomes, when you have a promising treatment, with no side-effects, can you morally withhold it from a population whose certain outcome is decline and death? Our critics would have us wait. Our choice was to release as much of the protocol for free as possible (see the free education on our website or review Dr. Bredesen’s books from the library), so that those with cognitive decline had the choice. Consequently, thousands of participants and their families have benefitted.
Through decades of work in his laboratory, Dr. Bredesen has developed the only Alzheimer’s hypothesis that has been tested on actual patients with success. We believe that you should have the option to follow it. Our critics believe that you should have to wait.
Ultimately, we’re happy you get to make that choice for yourself.
Dr. Dale Bredesen
An internationally-recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, his idea has placed Dr. Bredesen at the vanguard of neurological research and led to the discoveries that today underlie the ReCODE Report™.
For much more, read Dr. Bredesen’s direct response to his critics who’ve failed to offer professional cooperation and collaboration with the common goal of effective treatment for cognitive decline.
Julie Gregory
Hear from a patient representative, among the thousands benefitting from this approach, demanding change. Julie Gregory pushes back to the most vocal of Dr. Bredesen’s critics.
Demand Change NOW!
Make the Most Effective Alzheimer’s Treatment Widely Available
Join our army of activists demanding change from policymakers who are withholding effective treatment for one of the top ten leading causes of death worldwide. We’ll keep you apprised of how you can help spread the word and work to change the corrupt system that places profits above patients welfare.